If you focus on price action and tune out the noise, you can survive this market decline.
The market’s sharp decline has sent investors scrambling this week. Our collective attention is now on the possibility of the West getting dragged into yet another Middle Eastern conflict.
Of course, the media are asking all the wrong questions. Here’s my favorite so far:
Is Syria rocking the stock markets? Or is this a correction?
It’s exhausting listening to these arguments. Many investors (along with the financial media) spend so much of their time and energy trying to pinpoint the exact reasons behind every market move.
Don’t fall into this trap.
The market awards no extra points for determining whether chemical attacks in Syria or a lackluster durable goods number is the dominant factor that’s moving the markets. You can’t phone your broker and tell him to refund your losses from yesterday’s trading because the market is “just reacting to the bad news.”
Forget everything you think you know about the market right now. It’s time for some tunnel vision. Just the facts…
First, yesterday’s decline was broad and relentless. More than 80% of stocks trading on U.S. exchanges ended the day lower. That’s a change in character from the other declines we’ve seen so far this month. Momentum stocks held up relatively well—until yesterday.
Next, financial names continue to get hammered during this decline. Remember, these are the names that were leading the market higher earlier this summer.
The broad market has already retraced more than 50% of its summer rally. If stocks can’t find a floor soon, it will be time to start mapping out some revised price targets for the S&P…
for The Rude Awakening
Greg Guenthner, CMT, is the managing editor of The Rude Awakening. Greg is a member of the Market Technicians Association and holds the Chartered Market Technician designation.
I don't know how low the price of oil will ultimately go in the near future, but I do know that the seeds for an oil price recovery are already being planted by North American shale producers. These companies are dramatically slashing their capital spending plans for 2015, and I believe that the impact on production will surprise the markets…
Our discussions in these pages tend to freak new readers out. Dave Gonigam and Addison spent a fair amount of time last week discussing the implications of a deflationary environment and Fed policies on your existing portfolio. Dave sums up their conclusion in a neat gift box with a tight bow on it in today's essay.
Former editor-in-chief of Discover magazine Stephen Petranek has his eye on a special type of pharmaceutical company that has seen its stock price double since 2012. But the secret to this Midwestern company’s success is not based on drugs or innovation but something much deeper. Read on...
Yup, small-caps are setting up for a comeback year. In fact, I believe they'll retake a leadership role in the markets in 2015. So now's your chance to set yourself up for potentially massive gains before these stocks start grabbing headlines again. Or... you can simply wait until some ex-purt on CNBC or Fox recommends them - and miss out on half the party. Your choice...
"There has been an issue that has preoccupied my mind for a long time," writes Dr. Marc Faber. "In economics, it is generally accepted that if the quantity of money and credit is increased, prices will rise… However, since economics is so complex… I question whether the expansion of central banks' balance sheets and policies of zero interest rates could have a deflationary impact…" The good doctor wrestles with the question, in today's essay...